Effects of once-daily extended release quetiapine fumarate (quetiapine XR) on quality of life and sleep in elderly patients with major depressive disorder

Journal of Affective Disorders

Volumn 149, Issue 1-3, 2013, Pages 189-195

  Locklear, Julie C ^a   Svedsäter, Henrik ^b   Datto, Catherine ^a   Endicott, Jean ^c  

^a ASTRAZENECA   (United Kingdom)

^b ASTRAZENECA R AND D   (Sweden)

^c Columbia University ^*  (United States)

Author keywords

Major depressive disorder; Patient reported outcomes; Quality of life; Quetiapine XR; Sleep quality

Indexed keywords

PLACEBO; QUETIAPINE;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CONTROLLED STUDY; DEPRESSION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG RELEASE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONOTHERAPY; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PHASE 3 CLINICAL TRIAL; PITTSBURGH SLEEP QUALITY INDEX; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUALITY OF LIFE ENJOYMENT AND SATISFACTION QUESTIONNAIRE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RHEUMATIC POLYMYALGIA; SLEEP; SOMNOLENCE; SUICIDE ATTEMPT;

AGED; ANTIPSYCHOTIC AGENTS; DELAYED-ACTION PREPARATIONS; DEPRESSIVE DISORDER, MAJOR; DIBENZOTHIAZEPINES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; QUALITY OF LIFE; SLEEP; SLEEP DISORDERS;

EID: 84878498419     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.01.021     Document Type: Article

References (40)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders fourth ed. 2000 American Psychiatric Association Washington, DC Text Revision
2. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder, third ed. (2010). October, 2010. Available at: 〈http://psychiatryonline.org/content.aspx?bookid= 28§ionid=1667485〉 (accessed August 22, 2012).
3. M. Bauer, N. El-Khalili, C. Datto, J. Szamosi, and H. Eriksson A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder Journal of Affective Disorders 127 2010 19 30
4. M. Bauer, H.W. Pretorius, E.L. Constant, W.R. Earley, J. Szamosi, and M. Brecher Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study Journal of Clinical Psychiatry 70 2009 540 549
5. B. Bortnick, N. El-Khalili, M. Banov, D. Adson, C. Datto, S. Raines, W. Earley, and H. Eriksson Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo-controlled, randomized study Journal of Affective Disorders 128 2011 83 94
6. D.J. Buysse, C.F. Reynolds III, T.H. Monk, S.R. Berman, and D.J. Kupfer The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research Psychiatry Research 28 1989 193 213
7. A.J. Cutler, S.A. Montgomery, D. Feifel, A. Lazarus, M. Åström, and M. Brecher Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study Journal of Clinical Psychiatry 70 2009 526 539
8. Datto, C., Endicott, J., Svedsater, H., Locklear, J. Effect of extended release quetiapine fumarate (quetiapine XR) on quality of life and sleep in elderly patients with generalized anxiety disorder. Abstract Presented at the 16III Annual Meeting of the American Psychiatric Association, New Orleans, LA, USA, 22-26 May 2010.
9. K. Demyttenaere, H.F. Andersen, and E.H. Reines Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder International Clinical Psychopharmacology 23 2008 276 286
10. W. Earley, A. McIntyre, G. Wang, S. Raines, and H. Eriksson Double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder (MDD) International Journal of Psychiatry in Clinical Practice 12 2008 332
11. N. El-Khalili, M. Joyce, S. Atkinson, R.J. Buynak, C. Datto, P. Lindgren, and H. Eriksson Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study International Journal of Neuropsychopharmacology 13 2010 917 932
12. J. Endicott, J. Nee, W. Harrison, and R. Blumenthal Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure Psychopharmacology Bulletin 29 1993 321 326
13. J. Endicott, B. Paulsson, U. Gustafsson, H. Schiöler, and M. Hassan Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: improvements in quality of life and quality of sleep Journal of Affective Disorders 111 2008 306 319
14. K.E. Ensrud, T.L. Blackwell, S. Ancoli-Israel, S. Redline, K. Yaffe, S. Diem, D. Claman, and K.L. Stone Use of selective serotonin reuptake inhibitors and sleep disturbances in community-dwelling older women Journal of the American Geriatrics Society 54 2006 1508 1515
15. M.F. Folstein, S.E. Folstein, and P.R. McHugh Mini-mental state. A practical method for grading the cognitive state of patients for the clinician Journal of Psychiatric Research 12 1975 189 198
16. J.J. Gallo, and P.V. Rabins Depression without sadness: alternative presentations of depression in late life American Family Physician 60 1999 820 826
17. M. Hamilton A rating scale for depression Journal of Neurology, Neurosurgery and Psychiatry 23 1960 56 62
18. R.D. Hays, K.B. Wells, C.D. Sherbourne, W. Rogers, and K. Spritzer Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses Archives of General Psychiatry 52 1995 11 19
19. K. Hewett, W. Chrzanowski, R. Jokinen, R. Felgentreff, R.K. Shrivastava, M.D. Gee, D.S. Wightman, M.C. O'Leary, L.S. Millen, M.C. Leon, M.A. Briggs, A. Krishen, and J.G. Modell Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorder Journal of Psychopharmacology 24 2010 521 529
20. K. Hewett, W. Chrzanowski, M. Schmitz, A. Savela, V. Milanova, M. Gee, A. Krishen, L. Millen, M.O. Leary, and J. Modell Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR Journal of Psychopharmacology 23 2009 531 538
21. Katila, H., Mezhebovsky, I., Mulroy, A., Berggren, L., Eriksson, H., Earley, W., Datto, C., 2012. Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder. American Journal of Geriatric Psychiatry, Epub ahead of print.
22. M. Liebowitz, R.W. Lam, U. Lepola, C. Datto, D. Sweitzer, and H. Eriksson Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial Depression and Anxiety 27 2010 964 976
23. R.E. Maddux, K.K. Delrahim, and M.H. Rapaport Quality of life in geriatric patients with mood and anxiety disorders CNS Spectrums 8 2003 35 47
24. L.M. Martire, R. Schulz, C.F. Reynolds III, J.F. Karp, A.G. Gildengers, and E.M. Whyte Treatment of late-life depression alleviates caregiver burden Journal of the American Geriatrics Society 58 2010 23 29
25. J. Mendlewicz Sleep disturbances: core symptoms of major depressive disorder rather than associated or comorbid disorders World Journal of Biological Psychiatry 10 2009 269 275
26. S.A. Montgomery, and M. Åsberg A new depression scale designed to be sensitive to change British Journal of Psychiatry 134 1979 382 389
27. R. Morehouse, G. MacQueen, and S.H. Kennedy Barriers to achieving treatment goals: a focus on sleep disturbance and sexual dysfunction Journal of Affective Disorders 132 Suppl 1 2011 S14 S20
28. B. Navarro, F. Andres, I. Parraga, S. Morena, J.M. Latorre, and J. Lopez-Torres Approach to major depression in old people International Psychogeriatrics 22 2010 733 738
29. J.H. Park, J.J. Lee, S.B. Lee, Y. Huh, E.A. Choi, J.C. Youn, J.H. Jhoo, J.S. Kim, J.I. Woo, and K.W. Kim Prevalence of major depressive disorder and minor depressive disorder in an elderly Korean population: results from the Korean Longitudinal Study on Health and Aging (KLoSHA) Journal of Affective Disorders 125 2010 234 240
30. T.A. Pigott, A. Prakash, L.M. Arnold, S.T. Aaronson, C.H. Mallinckrodt, and M.M. Wohlreich Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder Current Medical Research and Opinion 23 2007 1303 1318
31. D. Riemann, and U. Voderholzer Primary insomnia: a risk factor to develop depression? Journal of Affective Disorders 76 2003 255 259
32. D.V. Sheehan, Y. Lecrubier, K.H. Sheehan, P. Amorim, J. Janavs, E. Weiller, T. Hergueta, R. Baker, and G.C. Dunbar The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 Journal of Clinical Psychiatry 59 Suppl 20 1998 22 33
33. R.C. Shelton, K.L. Haman, M.H. Rapaport, A. Kiev, W.T. Smith, R.M. Hirschfeld, R.B. Lydiard, J.M. Zajecka, and D.L. Dunner A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder Journal of Clinical Psychiatry 67 2006 1674 1681
34. A. Sir, R.F. D'Souza, S. Uguz, T. George, S. Vahip, M. Hopwood, A.J. Martin, W. Lam, and T. Burt Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms Journal of Clinical Psychiatry 66 2005 1312 1320
35. S.M. Stahl, M. Fava, M.H. Trivedi, A. Caputo, A. Shah, and A. Post Agomelatine in the treatment of major depressive disorder: an 8-week, multicenter, randomized, placebo-controlled trial Journal of Clinical Psychiatry 71 2010 616 626
36. J.F. van den Berg, H.J. Luijendijk, J.H.M. Tulen, A. Hofman, A.K. Neven, and H. Tiemeier Sleep in depression and anxiety disorders: a population-based study of elderly persons Journal of Clinical Psychiatry 70 2009 1105 1113
37. R. Weisler, M. Joyce, L. McGill, A. Lazarus, J. Szamosi, and H. Eriksson Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study CNS Spectrums 14 2009 299 313
38. Weisler, R.H., Joyce, M., McGill, L., Lazarus, A., Eriksson, H.A., 2008. Extended release quetiapine fumarate (quetiapine XR) monotherapy for major depressive disorder (MDD): a double-blind, placebo-controlled study. Poster Presented at the 60th Institute on Psychiatric Services, Chicago, IL, USA, 2-5 October.
39. K.B. Wells, A. Stewart, R.D. Hays, M.A. Burnam, W. Rogers, M. Daniels, S. Berry, S. Greenfield, and J. Ware The functioning and well-being of depressed patients. Results from the Medical Outcomes Study Journal of the American Medical Association 262 1989 914 919
40. S. Zisook, and N.S. Downs Diagnosis and treatment of depression in late life Journal of Clinical Psychiatry 59 Suppl 4 1998 80 91